| PERIOD ENDING | 31-Dec-08 | | Total Revenue | 35,589 | | Cost of Revenue | 24,703 | | | Gross Profit | 10,886 | | | Operating Expenses | | Research Development | 788 | | Selling General and Administrative | 13,271 | | Non Recurring | 57 | | Others | 843 | | | | Total Operating Expenses | 14,959 | | | | Operating Income or Loss | (4,073) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 4,454 | | Earnings Before Interest And Taxes | 381 | | Interest Expense | 866 | | Income Before Tax | (485) | | Income Tax Expense | (996) | | Minority Interest |
-
| | | | Net Income From Continuing Ops | 511 | | | Non-recurring Events | | Discontinued Operations | (2,147) | | Extraordinary Items |
-
| | Effect Of Accounting Changes |
-
| | Other Items |
-
| | | | Net Income | (1,636) | | Preferred Stock And Other Adjustments | (1,082) | | | Net Income Applicable To Common Shares | ($2,718) |
|
0.26% Nasdaq 
0.035 (10.00%) 
Income Statement
